ONCObind

About ExThera Medical

ExThera Medical is a clinical-stage medical device company pioneering a novel pathogen adsorption technology. Its core platform utilizes affinity blood filters with chemically-bonded, modified heparin to bind and remove pathogens, including viruses and bacteria, and circulating tumor cells directly from a patient's blood. The Seraph 100 filter received an Emergency Use Authorization (EUA) for COVID-19 during the pandemic and is now in clinical trials for broader bloodstream infections, while a second product, ONCObind, is in early development for metastatic cancer. The company is privately held, headquartered in Martinez, California, and is actively seeking investment for its next funding round.

Therapeutic Areas